Cancer BiologyMolecular OncologyPeer-reviewed
Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies
Veera K. Ojala, Sini Ahonen, Sara Peltola…·Kari J. Kurppa
This study identifies recurrent ERBB4 mutations with oncogenic potential and resistance to targeted therapies, suggesting clinical implications for treatment strategies.
2 citations